We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Releases Updated Policies Manual on Proprietary Naming of Drugs
CDER Releases Updated Policies Manual on Proprietary Naming of Drugs
To reduce medication errors, CDER on Friday released its revised policies and procedures on proprietary naming of drugs, which are sometimes misidentified because of the way they are spelled or how the names sound.